Matt Windsor

Matt Windsor

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Moon Nahm, M.D., has identified the crucial antibodies for pneumococcal vaccines and helped lower prices from $100 per dose to $2. With pilot funding from UAB’s urgent COVID-19 research initiative, Nahm is adapting his proven techniques to SARS-CoV-2.

Alabamians have early access to potentially life-saving vaccines and treatments for COVID-19 through UAB. Why? The same reasons that clinical trials activity at UAB has more than doubled in the past five years. Here's how it happened.

A bioluminescent one-two punch targets mitochondria in cancer cells and evades the blood-brain barrier for a potential new treatment for neuroendocrine cancers, triple-negative breast cancer and brain cancers.

UAB is enrolling patients as part of randomized controlled trials that experts say are necessary to prove the efficacy of the much-discussed COVID-19 treatment.

In a new trial funded through UAB’s urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.

Advice on mental and emotional well-being from UAB leadership and professional development expert Michael Wiederman, Ph.D.

Get the facts in this brief guide to testing requirements, methods and criteria.

Employees submitted more than 160 questions and comments during the virtual town hall Aug. 14; find answers to questions that couldn’t be answered live due to time constraints, including explanations of benefits, mask compliance, remote working expectations and more.

UAB leaders discussed data behind the university’s comprehensive reopening plan and answered questions on move-in, class schedules, mask distribution and more.

Page 10 of 28